生物分析測試服務市場規模、佔有率及成長分析（按分子、測試、工作流程、應用、最終用途和地區）－2025 年至 2032 年產業預測

2023 年生物分析測試服務市場規模價值 36 億美元，預計將從 2024 年的 41.8 億美元成長到 2032 年的 139 億美元，預測期間（2025-2032 年）的複合年成長率為 16.2%。

全球生物分析測試服務市場包括向製藥、生物製藥和生物技術產業提供的分析服務，以支援藥物開發和研究。這些服務涉及分析血液、尿液和組織等生物樣本，以測量藥物濃度、代謝物和生物標記物，從而評估藥物安全性、有效性和藥物動力學。委外研發機構（CRO）和專業服務供應商在提供這些重要服務方面發揮著至關重要的作用。生物分析測試服務市場的主要目標是提供可靠、準確的測試，以促進安全有效的藥物進入市場。然而，一些挑戰阻礙了市場成長。特別是生物分析測試服務的高成本令人望而卻步，特別是對於較小的製藥公司和研究機構。此外，生物分析測試固有的複雜性和技術挑戰可能會限制結果的效率和準確性，從而延長週轉時間並可能為資料解釋帶來問題。另一個主要問題是分析方法和程序缺乏標準化。方法上的差異會導致資料不一致，並使不同研究和實驗室之間的結果比較和檢驗變得複雜。這種缺乏統一性可能會阻礙藥物開發過程並延遲監管部門的核准。應對這些挑戰需要共同努力，標準化分析方法，投資先進技術以簡化流程，並實施具有成本效益的策略。這些措施對於克服現有障礙和推動生物分析測試服務市場的成長至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

生物分析測試服務市場規模（按分子和複合年成長率）（2025-2032）

• 市場概覽
• 小分子
• 大分子
  • 液相層析質譜研究
  • 免疫檢測
  • PK
  • ADA
  • 其他
• 其他

生物分析測試服務市場規模（按測試類型和複合年成長率）（2025-2032）

• 市場概覽
• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• 生物利用度
• 生物等效性
• 其他

生物分析測試服務市場規模（依工作流程及複合年成長率）（2025-2032）

• 市場概覽
• 樣品製備
  • 蛋白質沉澱
  • 液-液萃取
  • 固相萃取
• 樣品分析
  • 聯用技術
  • 層析法技術
  • 電泳
  • 配體結合試驗
  • 質譜法
  • 核磁共振
• 其他工作流程

生物分析測試服務市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 腫瘤學
• 神經病學
• 感染疾病
• 胃腸病學
• 心臟病學
• 其他用途

生物分析測試服務市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 製藥和生物製藥公司
• CDMO
• CRO

生物分析測試服務市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Charles River Laboratories（USA）
• Labcorp Drug Development（USA）
• Eurofins Scientific（Luxembourg）
• SGS SA（Switzerland）
• PPD, Inc.
• ICON plc（Ireland）
• Syneos Health（USA）
• Q2 Solutions（USA）
• Intertek Group plc（UK）
• Parexel International Corporation（USA）
• ACM Global Laboratories（USA）
• Frontage Laboratories, Inc.（USA）
• BioAgilytix（USA）
• KCAS Bioanalysis & Biomarker Services（USA）
• Pacific BioLabs（USA）

結論和建議

Bioanalytical Testing Services Market size was valued at USD 3.6 Billion in 2023 and is poised to grow from USD 4.18 Billion in 2024 to USD 13.9 Billion by 2032, growing at a CAGR of 16.2% during the forecast period (2025-2032).

The global bioanalytical testing services market encompasses analytical services provided to pharmaceutical, biopharmaceutical, and biotechnology industries to support drug development and research. These services involve analyzing biological samples-such as blood, urine, and tissues-to determine drug concentrations, metabolites, and biomarkers, thereby assessing drug safety, efficacy, and pharmacokinetics. Contract research organizations (CROs) and specialized service providers play a pivotal role in delivering these essential services. A primary objective of the bioanalytical testing services market is to furnish reliable and accurate testing to facilitate the introduction of safe and effective drugs into the market. However, several challenges impede market growth. Notably, the high costs associated with bioanalytical testing services can be prohibitive, particularly for smaller pharmaceutical companies and research institutions. Additionally, the complexity and technical difficulties inherent in bioanalytical testing can limit the efficiency and accuracy of results, leading to extended turnaround times and potential data interpretation issues. Moreover, the lack of standardization in analytical methods and procedures poses significant challenges. Variations in methodologies can lead to inconsistencies in data, complicating the comparison and validation of results across different studies and laboratories. This lack of uniformity can hinder the drug development process and delay regulatory approvals. Addressing these challenges necessitates concerted efforts to standardize analytical methods, invest in advanced technologies to streamline processes, and implement cost-effective strategies. Such measures are vital to overcoming existing barriers and fostering growth within the bioanalytical testing services market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioanalytical Testing Services Market Segments Analysis

Global Bioanalytical Testing Services Market is segmented by Molecule, Test, Workflow, Application, End Use and region. Based on Molecule, the market is segmented into Small Molecule, Large Molecule and Others. Based on Test, the market is segmented into ADME, PK, PD, Bioavailability, Bioequivalence and Others. Based on Workflow, the market is segmented into Sample Preparation, Sample Analysis and Other Workflow Processes. Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology and Other Applications. Based on End Use, the market is segmented into Pharma & BioPharma Companies, CDMO and CRO. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioanalytical Testing Services Market

The escalating number of pharmaceutical trials and the intensified focus on developing new drugs and biopharmaceuticals are significantly boosting the demand for bioanalytical testing services. These services are crucial for ensuring the accuracy and reliability of data, which in turn guarantees the efficacy and safety of pharmaceutical products. As pharmaceutical companies invest more in research and development, there is a corresponding increase in the need for comprehensive bioanalytical testing to support drug development and regulatory approval processes.

Restraints in the Bioanalytical Testing Services Market

The substantial expenses associated with bioanalytical testing, particularly for advanced specialized analyses, can pose significant challenges for smaller pharmaceutical companies and research institutions. These high costs often serve as barriers, potentially hindering the progression of drug development projects within these organizations.

Market Trends of the Bioanalytical Testing Services Market

The integration of biomarker discovery into bioanalytical testing projects is gaining momentum, reflecting its critical role in personalized medicine, early diagnosis, and targeted therapies. Biomarkers-biological molecules measurable in blood, tissues, or other fluids-provide insights into normal or pathological processes and treatment responses. Their identification and validation are essential for diagnosing diseases, predicting outcomes, and tailoring treatments. Advanced technologies, such as mass spectrometry, genomics, and proteomics, facilitate the precise detection and quantification of these biomarkers. By leveraging these cutting-edge tools, bioanalytical testing services enhance the development of novel treatments and diagnostic tools, thereby advancing precision medicine and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Bioanalytical Testing Services Market Size by Molecule & CAGR (2025-2032)

• Market Overview
• Small Molecule
• Large Molecule
  • LC-MS Studies
  • Immunoassays
  • PK
  • ADA
  • Others
• Others

Global Bioanalytical Testing Services Market Size by Test & CAGR (2025-2032)

• Market Overview
• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• Bioavailability
• Bioequivalence
• Others

Global Bioanalytical Testing Services Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sample Preparation
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
• Sample Analysis
  • Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
• Other Workflow Processes

Global Bioanalytical Testing Services Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Applications

Global Bioanalytical Testing Services Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharma & BioPharma Companies
• CDMO
• CRO

Global Bioanalytical Testing Services Market Size & CAGR (2025-2032)

• North America (Molecule, Test, Workflow, Application, End Use)
  • US
  • Canada
• Europe (Molecule, Test, Workflow, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Molecule, Test, Workflow, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Molecule, Test, Workflow, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Molecule, Test, Workflow, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Q2 Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgilytix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCAS Bioanalysis & Biomarker Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific BioLabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations